Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Randomised controlled trial of buddy support in the reduction of cardiovascular risk related behaviour
ISRCTN ISRCTN37146824
ClinicalTrials.gov identifier
Public title Randomised controlled trial of buddy support in the reduction of cardiovascular risk related behaviour
Scientific title
Acronym N/A
Serial number at source REC00155
Study hypothesis The study will test the hypothesis that buddy support significantly enhances the effect of lifestyle advice from a practice nurse. 700 adults aged 35-65 will receive advice and instruction in lifestyle modification designed to minimise cardiovascular risk factors. Participants will be randomly allocated to one of two conditions: solo or buddy. Buddy subjects will be allocated a buddy, a same-sex individual also from the buddy condition. Buddy pairs will be encouraged to maintain contact for six months in order to encourage each other to maintain lifestyle modifications. Solo participants (controls) will receive lifestyle advice from the nurse, but without peer support. Evaluation after six months will compare successful lifestyle modification (smoking, exercise, alcohol consumption, diet, body mass index, blood pressure) between solo and buddy groups.
Lay summary
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Cardiovascular disease
Participants - inclusion criteria Adults registered with participating practices, aged between 35 and 65.
Participants - exclusion criteria Patients with a history of use of psychotropic medication including antidepressants and benzodiazepines within the previous six months; a current or past history of psychotic illness, alcohol or drug abuse, or personality disorder; or with insufficient command of English for buddying to be practical.
Anticipated start date 01/04/1998
Anticipated end date 01/10/2000
Status of trial Completed
Patient information material
Target number of participants Not provided at time of registration
Interventions i. Buddy - allocated of a buddy, a same-sex individual also from the buddy condition. Buddy pairs will be encouraged to maintain contact for six months in order to encourage each other to maintain lifestyle modifications.
ii. Solo (controls) will receive lifestyle advice from the nurse, but with no peer support.
Primary outcome measure(s) Change in Body Mass Index, serum cholesterol, diastolic and systolic blood pressure, smoking cessation, exercise and alcohol consumption.
Secondary outcome measure(s) Not provided at time of registration
Sources of funding NHS Executive London, UK
Trial website
Publications
Contact name Dr  Martin  Edwards
  Address Jenner Health Centre
201 Stanstead Road
Forest Hill
  City/town London
  Zip/Postcode SE23 1HU
  Country United Kingdom
  Tel +44 (0)20 8690 2231
  Fax +44 (0)20 7771 4210
  Email cc@martinedwards.me.uk
Sponsor NHS R&D Regional Programme Register - Department of Health (UK)
  Address The Department of Health
Richmond House
79 Whitehall
  City/town London
  Zip/Postcode SW1A 2NL
  Country United Kingdom
  Tel +44 (0)20 7307 2622
  Fax +44 (0)20 7307 2623
  Email dhmail@doh.gsi.org.uk
  Sponsor website: http://www.doh.gov.uk
Date applied 23/01/2004
Last edited 08/12/2010
Date ISRCTN assigned 23/01/2004
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central